3 unknown. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 3 | Unknown 3 |
Follow Immunitor LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tableted COVID-19 Therapeutic Vaccine V-SARS - Covid19 | Phase 1 / Phase 2 | Unknown | Immunitor LLC | 20 | 2020-05-15 | 2020-05-27 |
| Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer V3-P - Pancreatic Cancer Non-resectable | Phase 1 / Phase 2 | Unknown | Immunitor LLC | 30 | 2017-05-01 | 2019-08-30 |
| Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma Oral therapeutic vaccine V3-X to treat cholangiocarcinoma - Cholangiocarcinoma | Phase 1 / Phase 2 | Unknown | Immunitor LLC | 20 | 2017-02-20 | 2019-08-30 |
COVID-19 (1) · Cholangiocarcinoma (1) · Coronavirus Infections (1) · Pneumonia (1) · Respiration Disorders (1)
Mongolia (3) · Canada (1)
Aldar Bourinbayar, MD/PhD (1) · Allen Bain, PhD (1)